Linked Life Data

1558118

Source:http://linkedlifedata.com/resource/pubmed/id/1558118

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1992-5-4
pubmed:abstractText
We treated 14 consecutive patients for acute central retinal artery occlusion. Eleven were treated with urokinase introduced through a microcatheter in the proximal segment of the ophthalmic artery. Fibrinolysis was succeeded by heparinization for two to three days. Instead of urokinase, we used tissue plasminogen activator in three patients. Vision improved markedly in four of the 14 patients. Five others had slight improvement of visual acuity, visual field, or both. In five patients, no change occurred. Such a recovery of visual acuity may be anticipated if treatment begins within the first few hours after the onset of central retinal artery occlusion. A control group of 41 consecutive patients treated conservatively showed almost no improvement in visual acuity. Eleven of these 41 patients were treated within the first six hours after the patient noticed the onset of blindness.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0002-9394
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
113
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
429-34
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Microcatheter urokinase infusion in central retinal artery occlusion.
pubmed:affiliation
University Eye Clinic, Albert-Ludwigs-Universität, Freiburg, Germany.
pubmed:publicationType
Journal Article, Case Reports